CH CASTSON 81 (00810) announced a net loss of 6.892 million Hong Kong dollars for the performance in 2025, a year-on-year decrease of 68.09%.
China Zhuchen 81 (00810) announced its performance in 2025, with total revenue of HKD 348,000, a year-on-year increase of 6.1%; net loss of HKD 6.892 million, a year-on-year decrease of 68.09%; loss per share of 3.56 HK cents.
CH CASTSON 81 (00810) announced its performance for the year 2025, with total revenue of 348,000 Hong Kong dollars, a year-on-year increase of 6.1%; net loss of 6,892,000 Hong Kong dollars, a year-on-year reduction of 68.09%; loss per share of 3.56 Hong Kong cents.
Related Articles

NC Healthcare (01518) released its annual performance, reporting a net loss of 115 million yuan attributable to shareholders, a turnaround from profit to loss compared to the previous year.

SOFTMEDX (00648) released its annual performance, with a net profit of HK$6.95 million, a decrease of 97.87% year-on-year.

LAI SUN INT'L (00191) announced its interim financial results, with a net loss attributable to shareholders of HK$682 million, representing a 453.4% increase year-on-year.
NC Healthcare (01518) released its annual performance, reporting a net loss of 115 million yuan attributable to shareholders, a turnaround from profit to loss compared to the previous year.

SOFTMEDX (00648) released its annual performance, with a net profit of HK$6.95 million, a decrease of 97.87% year-on-year.

LAI SUN INT'L (00191) announced its interim financial results, with a net loss attributable to shareholders of HK$682 million, representing a 453.4% increase year-on-year.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


